355 related articles for article (PubMed ID: 19944886)
41. Treatment outcomes of an integrated residential programme for patients with schizophrenia and substance use disorder.
Morrens M; Dewilde B; Sabbe B; Dom G; De Cuyper R; Moggi F
Eur Addict Res; 2011; 17(3):154-63. PubMed ID: 21447952
[TBL] [Abstract][Full Text] [Related]
42. Comorbid schizophrenia and substance abuse.
Green AI; Brown ES
J Clin Psychiatry; 2006 Sep; 67(9):e08. PubMed ID: 17081075
[TBL] [Abstract][Full Text] [Related]
43. Clozapine for substance-abusing schizophrenic patients.
Tsuang JW; Eckman TE; Shaner A; Marder SR
Am J Psychiatry; 1999 Jul; 156(7):1119-20. PubMed ID: 10401473
[No Abstract] [Full Text] [Related]
44. Schizophrenia with impulsive and aggressive behaviors.
Lindenmayer JP; Kanellopoulou I
Psychiatr Clin North Am; 2009 Dec; 32(4):885-902. PubMed ID: 19944890
[TBL] [Abstract][Full Text] [Related]
45. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.
Ziedonis DM; Smelson D; Rosenthal RN; Batki SL; Green AI; Henry RJ; Montoya I; Parks J; Weiss RD
J Psychiatr Pract; 2005 Sep; 11(5):315-39. PubMed ID: 16184072
[TBL] [Abstract][Full Text] [Related]
46. Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine.
Mesholam-Gately RI; Gibson LE; Seidman LJ; Green AI
Schizophr Res; 2014 May; 155(1-3):45-51. PubMed ID: 24685823
[TBL] [Abstract][Full Text] [Related]
47. The cost of treating substance abuse patients with and without comorbid psychiatric disorders.
Hoff RA; Rosenheck RA
Psychiatr Serv; 1999 Oct; 50(10):1309-15. PubMed ID: 10506299
[TBL] [Abstract][Full Text] [Related]
48. Medication non-compliance and substance abuse in schizophrenia.
Maheshwari SK; Gupta S; Sharan P
Nurs J India; 2009 Sep; 100(9):201-3. PubMed ID: 20151613
[No Abstract] [Full Text] [Related]
49. Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder.
Potvin S; Pampoulova T; Mancini-Marië A; Lipp O; Bouchard RH; Stip E
J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):796-8. PubMed ID: 16705205
[TBL] [Abstract][Full Text] [Related]
50. Treatment of substance use disorders in schizophrenia.
Bennett ME; Bradshaw KR; Catalano LT
Am J Drug Alcohol Abuse; 2017 Jul; 43(4):377-390. PubMed ID: 27715317
[TBL] [Abstract][Full Text] [Related]
51. Treatment of patients with schizophrenia and substance abuse disorders.
Tsuang J; Fong TW
Curr Pharm Des; 2004; 10(18):2249-61. PubMed ID: 15281900
[TBL] [Abstract][Full Text] [Related]
52. Pharmacological treatment of schizophrenia and co-occurring substance use disorders.
Smelson DA; Dixon L; Craig T; Remolina S; Batki SL; Niv N; Owen R
CNS Drugs; 2008; 22(11):903-16. PubMed ID: 18840032
[TBL] [Abstract][Full Text] [Related]
53. Marijuana use in schizophrenia: a clear hazard.
Treffert DA
Am J Psychiatry; 1978 Oct; 135(10):1213-5. PubMed ID: 29496
[TBL] [Abstract][Full Text] [Related]
54. Pharmacotherapy for schizophrenia and co-occurring substance use disorders.
Green AI
Neurotox Res; 2007 Jan; 11(1):33-40. PubMed ID: 17449446
[TBL] [Abstract][Full Text] [Related]
55. Combining risperidone with standard neuroleptics for refractory schizophrenic patients.
Bacher NM; Kaup BA
Am J Psychiatry; 1996 Jan; 153(1):137. PubMed ID: 8540580
[No Abstract] [Full Text] [Related]
56. Diagnosis and management of substance use disorders among inpatients with schizophrenia.
Kirchner JE; Owen RR; Nordquist C; Fischer EP
Psychiatr Serv; 1998 Jan; 49(1):82-5. PubMed ID: 9444685
[TBL] [Abstract][Full Text] [Related]
57. Substance abuse treatment for people with schizophrenia.
Bellack AS; Gearon JS
Addict Behav; 1998; 23(6):749-66. PubMed ID: 9801714
[TBL] [Abstract][Full Text] [Related]
58. Management of schizophrenia with suicide risk.
Roy A; Pompili M
Psychiatr Clin North Am; 2009 Dec; 32(4):863-83. PubMed ID: 19944889
[TBL] [Abstract][Full Text] [Related]
59. Management of hepatitis C disease among VA patients with schizophrenia and substance use disorders.
Huckans MS; Blackwell AD; Harms TA; Hauser P
Psychiatr Serv; 2006 Mar; 57(3):403-6. PubMed ID: 16525001
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological treatment of schizophrenia with comorbid substance use disorder.
Azorin JM; Simon N; Adida M; Belzeaux R
Expert Opin Pharmacother; 2016; 17(2):231-53. PubMed ID: 26635059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
